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Abstract Although herpes simplex virus type-1 (HSV-1),
and type-2 (HSV-2), Staphylococcus aureus and Candida
albicans co-habit the oral and genital mucosa, their inter-
action is poorly understood. We determined the effect HSV
has on bacterial and/or fungal adherence, the initial step in
biofilm formation. HeLa229 cells were infected with HSV-
1 (KOS) gL86 or HSV-2 (KOS) 333gJ2 at a multiplicity of
infection (MOI) of 50 and 10. S. aureus (ATCC 25923)
and/or C. albicans (yeast forms or germ tube forms) were
co-incubated for 30 min (37 C; 5 % CO2; 5:1 organism:
HeLa cell ratio; n = 16) with virus-infected HeLa cells or
uninfected HeLa cell controls. Post-incubation, the mono-
layers were washed (3x; PBS), lysed (RIPA), and the lysate
plated onto Fungisel and/or mannitol salts agar for standard
colony count. The level of HeLa-associated S. aureus was
significantly decreased (P\ 0.05) for both HSV-1- and
HSV-2-infected cells, as compared to virus-free HeLa cell
controls (38 and 59 % of control, respectively). In contrast,
HSV-1 and HSV-2 significantly (P\ 0.05) enhanced HeLa
cell association of C. albicans yeast forms and germ tube
approximately two-fold, respectively. The effect of S.
aureus on germ tube and yeast form adherence to HSV-1-
and HSV-2-infected cells was specific for the Candida
phenotype tested. Our study suggests that HSV, while
antagonist towards S. aureus adherence enhances Candida
adherence. Furthermore, the combination of the three
pathogens results in S. aureus adherence that is either
unaffected, or partially restored depending on both the
herpes viral species and the fungal phenotype present.
Introduction
Adherence to cell surfaces is an essential initial stage in
microbial colonization and subsequent biofilm formation
[58, 77]. Shared sites of persistent colonization and chronic
infection for Staphylococcus aureus, Candida albicans,
and HSV are the oronasopharynx and genital tract. S.
aureus and C. albicans, both commensals, are also the 2nd
and 4th most common cause of bloodstream infections,
respectively [54, 79]. Of the various sites of S. aureus and
C. albicans co-colonization, the oronasopharynx serves as
the reservoir for systemic infections [44]. Within the
oronasopharynx, S. aureus, C. albicans, and HSV occupy
two distinct geographic niches. In hosts with dentition, the
oral mucosa is shared by HSV and C. albicans, while the
anterior nasal nares are occupied by S. aureus [21]. Clin-
ically, S. aureus is only rarely isolated from oral-pharyn-
geal specimens when normal tissue is present, despite
in vitro findings that S. aureus adheres to buccal epithelial
cells [22, 51]. Interestingly, in the presence of dentures, an
abiotic surface, S. aureus forms a robust biofilm on the
denture surface along with C. albicans [29, 63]. Little is
known concerning genital tract co-colonization niches
beyond the clinical findings that S. aureus infection is
associated with genital inflammation, discharge, and dys-
pareunia, while C. albicans and HSV produce mucosal
lesions similar to those observed in the oral cavity [25, 39,
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46, 55, 59]. Whether present in the oronasopharynx or
genital tract, it is a near certainty that S. aureus and C.
albicans would interact at some point with HSV, a per-
manent resident of infection sites [5].
HSV, a major cause of morbidity and mortality, is a life-
long pathogen present in[90 % of the world population [11,
71]. In immune-competent individuals, HSV-1 is a major
cause of gingivostomatitis, as well as genital herpes, due to
changes in sexual behaviors [5, 48]. Similar to HSV-1, HSV-
2 causes oral lesions, although it has a higher association
with genital lesions [7, 72]. A characteristic of herpes
infections is chronic persistent viral shedding in the absence
of symptoms [65, 67]. This permanent, albeit intermittent,
presence of HSV virions may play a role in regulating the
host microbiome. This could be accomplished via an alter-
ation in available cell surface receptors for adherence by
other members of the microbiome. [6, 8–10, 12, 16, 19, 21,
53]. Using a HeLa cell model of virus infection, the focus of
this study was to determine whether HSV-1 or HSV-2 affect
S. aureus and/or C. albicans germ tube and yeast form
adherence, the initial step in biofilm formation.
Methods
Microbial Strains and Handling
Recombinant spread-deficient, entry proficient strains of
HSV-1(KOS) gL86 and HSV-2 (KOS) 333gJ- encoding a
beta-galactosidase reporter activity were used [3, 37, 68, 74].
Both virus strains enter and replicate, thus have the potential
to induce cell signaling, but lack the genes essential for viral
cell-to-cell spread. All virus used in this study were taken
from a single lot. Virus stocks were maintained at -80 C
until use. HSV entry into HeLa cells was confirmed by o-
nitrophenyl-b-D-galactopyranoside (ONPG) and 5-bromo-
4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) assays,
as previously described [52]. HeLa 229 cells were main-
tained and cultivated at 37 C, 5 % CO2 in 19 Dulbecco’s
modified Eagle’s medium (DMEMwith 4.5 g/L glucose and
L-glutamine, without sodium pyruvate; Mediatech) supple-
mentedwith 10 %heat-inactivated fetal bovine serum (FBS)
and gentamicin (50 lg/ml).
Candida albicans, maintained at -80 C until use, was
initially subcultured onto Sabourad Dextrose agar. For use,
C. albicans was cultured onto Fungisel medium (37 C;
48 h;Troy Biologics). Yeast suspensions (YF) were pre-
pared in Hanks Balanced Salts Solution (HBSS; 105 CFU/
ml final concentration; 37 C) immediately prior to use.
Germ tube forms (GT) were generated by incubation in
fetal bovine serum (FBS; 3 h; 37 C; Abs600 0.3), followed
by washing in HBSS (29; 40009g) and re-suspension in
HBSS to 105 CFU/ml final concentration.
Staphylococcus aureus ATCC 25923, maintained at
-80 C until use, was subcultured onto mannitol salts
medium (37 C; 18 h) for use. S. aureus suspensions were
prepared immediately prior to use in HBSS (105 CFU/ml
final concentration; 37 C).
Polymicrobic Adherence Assay
The number of HeLa cell-associated S. aureus and C.
albicans was determined as an indicator of biofilm initia-
tion (adherence). HeLa 229 were grown overnight in
96-well (4 9 104 cells/well) at 37 C, 5 % CO2 to reach
85 % final confluence. Before infection with virus, the cells
were washed with 19 Opti-MEM with HEPES, sodium
bicarbonate and L-glutamine (Gibco). Virus (HSV-1 (KOS)
gL86 or HSV-2 (KOS) 333gJ2) was added to HeLa 299
cells at a multiplicity of infection (MOI) of 50 and 10 for
3 h at 37 C, 5 % CO2. After viral infection, the cells were
washed once each with PBS then HBSS before incubation
with C. albicans YF or GT with and without S. aureus (5:1
target to cell ratio; n = 16). After incubation (30 min;
37 C; 5 % CO2), HeLa cell monolayers were washed to
remove unbound microbes (PBSx3) and lysed (RIPA, Life
Technologies, 1:50 dilution; filter sterilized). The cell
lysate (50 ll) was spread plated onto mannitol salts and/or
Fungisel agar to select for S. aureus and C. albicans,
respectively. Controls consisted of HSV-uninfected HeLa
cells handled as described for virus-infected HeLa cells.
For each experiment, a separate control plate to confirm the
viral MOI was performed.
Imaging studies of HSV-1- and HSV-2-infected (MOI
50; 3 h; 37 C) HeLa cell monolayers (5 9 104
cells/coverslip) were performed by both fluorescent
microscopy and bright field microscopy. Cell monolayers
were incubated (30 min; 37 C; 5 % CO2) with S. aureus
and C. albicans (5:1 target to cell). HeLa cells were then
washed free of non-adherent microbes (PBSx3) and fixed
(methanol). For fluorescent microscopy, monolayers were
stained with FITC-conjugated Herpes Simplex Virus Type
1?2 gD antibody (Abcam), and 40,6-diamidino-2-
phenylindole (DAPI; Life Technologies) then examined by
epi-fluorescent microscopy. Cells that were signal positive
for HSV or Candida or S. aureus (100 individual cells per
microbe signal per coverslip) were secondarily scanned for
the presence of additional microbe co-localization signals
(10009 initial magnification; Nikon). For bright field
microscopy, cell monolayers were stained with Gram’s
crystal violet (Troy Biologics), then examined by light
microscopy. Cells that were positive for Candida or S.
aureus (100 individual cells per microbe signal per cov-
erslip) were secondarily scanned for the presence of addi-
tional microbe co-localization signals (10009 initial
magnification).
530 B. J. Plotkin et al.: Herpes Simplex Virus (HSV) Modulation of Staphylococcus aureus…
123
Statistical Analysis
Each adherence experiment was conducted twice in octu-
plicate. Each imaging study was conducted twice in trip-
licate. Data were evaluated by analysis of variance
(ANOVA; GraphPad InStat 3.10 for Windows, GraphPad
Software Inc.). Mean values were considered significantly
different at P\ 0.05.
Results
Candida, HSV-1 and HSV-2 Modulation of S. aureus
Adherence to HeLa Cells
Since HSV-1 and HSV-2 co-localize in the oropharynx
with C. albicans, we first determined their effect alone, and
in concert, on S. aureus adherence to virus-infected HeLa
cells as compared to S. aureus adherence to virus-free
HeLa cells. Both HSV-1- and HSV-2-affected S. aureus
adherence to HeLa cells (Fig. 1a, b). At the highest virus
concentration (MOI 50) the level of S. aureus adhered to
uninfected HeLa cells (24.2 CFU/well ± 3.19; n = 16)
was significantly higher (2.7-fold; P\ 0.05) than that
measured for S. aureus adherence to HSV-1-infected HeLa
cells (9.1 ± 1.1 CFU/well). Staphylococcal adherence to
uninfected HeLa cells was also significantly (1.7-fold;
P\ 0.05) higher than that measured for adherence to
HSV-2 (MOI 50)-infected HeLa cells. The level of S.
aureus adherence to HSV-2-infected cells at a fivefold
lower MOI (MOI 10) was similar to that measured for the
HSV-2 MOI 50 (1.9-fold below virus-free control).
Co-incubation of S. aureus with C. albicans germ tube
(GT) forms restored the level of S. aureus adherence to
HSV-1 and HSV-2-infected HeLa cells to that measured
for uninfected HeLa cell controls. Similar to the effect of
GT forms, S. aureus adherence to HSV-2-infected cells in
the presence of C. albicans yeast forms (YF) resulted in
staphylococcal adherence levels similar to that measured
uninfected HeLa cells. In contrast, the presence of YF did
not affect the HSV-1 mediated depression in S. aureus
adherence. These results show that HSV viral entry is
antagonist to S. aureus adherence, an antagonism that can
be, in part, reversed by C. albicans GT and YF.
C. albicans Adherence to HSV-1- and HSV-2-
Infected HeLa Cells in the Presence and Absence
of S. aureus
In these assays, we determined whether C. albicans GT and
YF adherence to HeLa cells was affected by HSV and S.
aureus (Fig. 1c–f). Our findings showed that HSV-1 and
HSV-2 significantly (P\ 0.05) enhanced C. albicans GT
and YF adherence in a virus dose-dependent manner;
maximal adherence levels of GT and YF occurred at an
MOI of 50. For both candidal phenotypes, adherence was
significantly higher (P\ 0.05) than that measured for
adherence to virus-uninfected HeLa cell controls. Candida
GT adherence to HSV-2-infected HeLa cells (normalized
to virus-uninfected HeLa cell controls) was significantly
(P\ 0.05) higher than its adherence to HSV-1-infected
HeLa cells (3.6-fold vs. 1.9-fold higher, respectively). The
reverse pattern was observed for YF adherence. YF sig-
nificantly (P\ 0.05) and preferentially adhered to HSV-1-
infected cells (2.7-fold over uninfected control) as com-
pared to YF adherence to HSV-2-infected cells (1.9-fold
over uninfected control).
The HSV-mediated enhancement of YF and GT adher-
ence was significantly (P\ 0.05) and preferentially
affected by the presence of S. aureus. S. aureus decreased
GT adherence to HSV-2-infected cells to levels measured
for uninfected HeLa cell control. In contrast, S. aureus
significantly (P\ 0.05) decreased YF adherence to HSV-
1-infected HeLa cells. S. aureus had no significant effect
on YF adherence to HSV-2-infected cells or GT adherence
to HSV-1-infected HeLa cells. Taken together, these
results indicate that HSV promotes the association of C.
albicans in a phenotypic-specific manner. Furthermore,
these findings indicate that S. aureus’ effect on C. albicans
adherence was HSV-type specific with regard to fungal
phenotype.
Microscopic Evaluation of C. albicans and S. aureus
Adherence Pattern to HSV-1- and HSV-2-Infected
HeLa Cells
We visually examined the association of S. aureus and C.
albicans with HSV-1- and HSV-2-infected HeLa cells
using the size, morphology, and arrangement differences
between S. aureus and C. albicans to distinguish between
the organisms. In the absence of HSV-1 or HSV-2, S.
aureus and C. albicans (GT and YF) co-localized onto
uninfected HeLa control cells (Fig. 2a). In contrast, no co-
localization of staphylococci with C. albicans was
observed on HSV-1- or HSV-2-infected HeLa cells
(Fig. 2b–d). Using fluorescent microscopy with FITC-
conjugated anti-HSV-gD monoclonal antibody, we further
confirmed that S. aureus (Fig. 3b, c) did not co-localize
with C. albicans, HSV-1 or HSV-2 (Fig. 3a, a1, 3d).
However, Candida co-localized with HSV-1 and HSV-2
(Fig. 3a1, c). S. aureus and C. albicans were not observed
microscopically to interact with one another (data not
shown). Furthermore, the co-localization adherence pattern
of S. aureus and Candida, in the absence of HSV, indicates
a lack of physical interference with each other’s adherence.
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These findings further suggest a depletion of available S.
aureus adherence receptors subsequent to HSV cell entry.
Discussion
In this report, we describe an in vitro model system to
study the polymicrobial interactions which occur at the
initiating step in biofilm formation, i.e., adherence. The use
of HeLa cells in this model system presents a unique
advantage in the study of microbial interactions regarding
cell surface receptors as they lack surface expression of
fibronectin [4, 13, 27]. This absence of surface fibronectin
more closely mimics that observed in colonization and
natural infection, since the apical surface of mucosal
epithelia normally lacks fibronectin [18, 33, 38, 49, 66].
This absence of fibronectin also allows for the study of






























































































































































































































































































Fig. 1 Effect of HSV-1 (panels
a, c, e) and HSV-2 (panels b, d,
f) at multiplicities of infection
(MOI) of 50 and 10 on
adherence of S. aureus and/or C.
albicans to HeLa cells. a S.
aureus (Sa) binding to HSV-1-
infected cells in the presence of
C. albicans germ tubes (GT) or
yeast forms (YF); b S. aureus
(Sa) binding to HSV-2-infected
cells in the presence of C.
albicans germ tubes (GT) or
yeast forms (YF); c C. albicans
germ tubes (GT) binding to
HSV-1-infected cells in the
presence of S. aureus (Sa); d C.
albicans germ tubes (GT)
binding to HSV-2-infected cells
in the presence of S. aureus
(Sa); e C. albicans yeast forms
(YF) binding to HSV-1-infected
cells in the presence of S.
aureus (Sa); f C. albicans yeast
forms (YF) binding to HSV-2-
infected cells in the presence of
S. aureus (Sa). All data points
are mean ± SEM, n = 16
normalized to virus-free control.
*Significantly different
(P\ 0.05) from uninfected
HeLa cell control. #Significantly
different (P\ 0.05) from paired
point indicated by bracket
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adhere to HSV-infected cells since both microbes adhere to
fibronectin [2, 4, 13, 40, 69]. This model system for the
study of virus effects on bacterial and fungal adherence
was further enhanced through the use of entry and repli-
cation proficient, but non-spreading strains of HSV-1 and
HSV-2 [3, 74].
HSV enters cells via endocytosis [56, 57]. Endocytosis
of the virus-receptor complex results in a dynamic display
of cell surface receptors available to S. aureus and C.
albicans for their adherence. Interestingly there is an
opposing interaction of S. aureus and C. albicans with
heparan sulfates on the mammalian cell surface. S. aureus
adherence to various sulfonated heparans, particularly a
heparan component syndecan-1, is important in its inter-
action with epithelial cells [31, 36, 42, 47, 61, 73]. In
contrast, the presence of cell surface heparan sulfates block
C. albicans adherence to extracellular matrix proteins, e.g.,
laminin, and types I and IV collagen [43]. HSV cell entry
causes a species specific (HSV-1 vs. HSV-2) differential
depletion of heparan sulfates, and induction of heparanase
secretion, which further depletes cell surface sulfonated
heparans [1, 14, 20, 28, 30, 35, 41, 45, 56, 57, 70, 75]. Both
these events seem critical in our observations. For instance,
loss of S. aureus heparan sulfate receptors could explain
the lack of its adherence to HeLa cells infected with either
HSV-1 or HSV-2 (Fig. 4). Conversely, Candida preferred
receptors would be unmasked by heparanase production
and HSV entry depletion of surface heparan sulfates. The
HSV-1 vs. HSV-2 differential depletion of sulfonated
heparan receptors could explain our findings of enhanced
adherence to virus-infected cells that was Candida phe-
notype (YF-GT) dependent (Fig. 4) [45].
Although this model begins to address the patterns
measured for S. aureus and C. albicans adherence to HSV-
infected cells, a secondary mechanism is likely responsible
for the effects of S. aureus and C. albicans on each other’s
adherence in the presence of both uninfected and HSV-
infected (50 % HeLa cells infected/well, MOI50) cells.
Fig. 2 Lack of S. aureus and C. albicans interactions on HSV-1- and
HSV-2-infected HeLa cells. HSV-1 and HSV-2-infected (MOI 50)
HeLa cell monolayers with S. aureus and C. albicans (5:1 target to
cell). For bright field microscopy, cell monolayers were stained with
Gram’s crystal violet, then examined by light microscopy. Cells that
were positive for Candida or S. aureus (100 individual cells per
microbe signal/per coverslip) for were secondarily scanned for the
presence of additional microbe co-localization signals (91000 initial
magnification). a—a1 S. aureus (Sa) and C. albicans yeast forms
(YF) or germ tube forms (GT) co-localize on uninfected HeLa cells;
a2 (insert) Percent of HeLa cells with co-localized or individual
microbes; b—b3 Lack of S. aureus and C. albicans co-localization in
the presence of HSV-1; c—c2 Lack of S. aureus and C. albicans co-
localization in the presence of HSV-2; mean ± SEM
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HSV-infected cells release interferons alpha and gamma,
which in turn cause perturbation of lipid rafts altering
membrane fluidity (hydrophobicity) and the cell
cytoskeletal complex in non-virally infected cells [24, 34,
60, 64, 72]. Both S. aureus and C. albicans interact with
hydrophobic surfaces [2, 21, 32]. The secondary extrinsic
HSV-mediated effects on uninfected cells, i.e., surface
hydrophobicity changes, could result in increased S. aureus
and C. albicans adherence and the apparent restoration of
cell binding. The lack of cell-to-cell spread of the virus in
this model system will allow for determination of which
virally mediated cell alteration, i.e., intrinsic, extrinsic, or a
combination of changes, is responsible for the differential
adherence by S. aureus and C. albicans [2, 21].
The finding herein that HSV-1 and HSV-2 renders cells
refractory to S. aureus adherence, while enhancing phe-
notype specific C. albicans adherence, as well as
predilection for differential fungal phenotype adherence
mediated by HSV-1 (yeast form) vs. HSV-2 (germ tube
form) begin to explain host colonization sites and may play
a role directing maintenance of the candidal commensal
(YF) versus pathogenic state (GT) in vivo, e.g., HSV-2
may impact the incidence of vaginal candidiasis. These
positive interactions between HSV and C. albicans may
also provide an environment more conducive to HSV
survival. Recently it has been shown that HSV-1 becomes
embedded in the fungal biofilm where it remains viable and
protected from antiviral agents, as well host factors, e.g.,
antibodies [50]. This protection of HSV from host factors is
augmented by Candida’s ability to downregulate host
proinflammatory cytokine secretion, which would be
detrimental to HSV replication [17, 23, 26, 76]. HSV-1 in
turn has been shown to protect Candida by down-regulat-
ing antifungal immune response [15]. Both HSV and
Candida would benefit from the exclusion of S. aureus
from their neighborhood. S. aureus is a proinflammatory
pathogen [80]. In addition to the induction of various
cytokines, including interferon gamma, the chronic pres-
ence of S. aureus elicits a leukocytic infiltrate comprised
neutrophils, T cells and natural killer cells [62, 78]. Such a
Fig. 3 Lack of co-localization of S. aureus with C. albicans on HSV-
1- or HSV-2-infected HeLa cells. HSV-infected HeLa cell monolay-
ers challenge with S. aureus and C. albicans (5:1 target to cell)
stained (FITC-conjugated anti-HSV gD antibody, and DAPI). Pictures
are representative of findings from screening of cells that were signal
positive for HSV then scanned for Candida and S. aureus (100
individual cells per microbe signal per coverslip) that were then
secondarily scanned for the presence of additional microbe co-
localization signals (91000 initial magnification; Nikon). a—a4 C.
albicans (a2 insert; DAPI staining) co-localize with HSV-1; b-b3 C.
albicans co-localized with HSV-2 (b1 insert, C. albicans DAPI
staining); mean ± SEM
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proinflammatory response would be detrimental to both
HSV and candidal survival.
To our knowledge this is the first report demonstrating
the ability of HSV to regulate the adherence of multiple
opportunistic pathogens that are part of the inter-kingdom
microbiome. This study demonstrates that HSV-1 and
HSV-2 modulate both fungal and bacterial adherence to
cells, likely, in part, through HSV alteration of heparan
sulfate cell surface display. These findings represent a
paradigm shift from the current view that host factors
solely control microbiome population members, to one
where a life-long latent viral pathogen could co-opt the
host by a specific molecular mechanism that alters biofilm
initiation, thus, usurping regulatory control of microbiome
membership. Further studies are needed to define the
specific role the various HSV viral entry receptors play in
modulation of staphylococcal and candidal adherence. By
understanding the initial interactions that occur between
HSV-1 and HSV-2 as permanent members of the host
microbiome, and chronic colonizers, e.g., S. aureus and C.
albicans, another avenue opens with regard to biofilm
inhibition and eradication.
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